Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Molina Healthcare ( (MOH) ) is now available.
On August 12, 2025, Molina Healthcare amended its Credit Agreement to include a $500 million Delayed Draw A-2 Commitment, maturing on August 12, 2027. The company plans to use this loan to partially fund its stock repurchase program, addressing timing issues with subsidiary dividends, which may impact its financial strategy and shareholder value.
The most recent analyst rating on (MOH) stock is a Hold with a $341.00 price target. To see the full list of analyst forecasts on Molina Healthcare stock, see the MOH Stock Forecast page.
Spark’s Take on MOH Stock
According to Spark, TipRanks’ AI Analyst, MOH is a Neutral.
Molina Healthcare’s stock score is primarily influenced by its robust financial performance and undervalued P/E ratio, suggesting potential for investment. However, bearish technical indicators and challenges highlighted in the earnings call, such as revised guidance and cost pressures, weigh down the overall score. Investors should remain cautious due to the mixed sentiment and technical downtrend.
To see Spark’s full report on MOH stock, click here.
More about Molina Healthcare
Molina Healthcare, Inc. operates in the healthcare industry, primarily providing managed health care services under the Medicaid and Medicare programs. The company focuses on serving low-income families and individuals, offering health plans and related services across various U.S. states.
Average Trading Volume: 1,250,395
Technical Sentiment Signal: Sell
Current Market Cap: $8.34B
Find detailed analytics on MOH stock on TipRanks’ Stock Analysis page.